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Analysis of Aneuploidy in First-Cleavage
Mouse Embryos Fertilized in Vitro
and in Vivo
by Lynn R. Fraser* and Ian Maudlint
First-cleavage mouse embryos, fertilized in vitro and in vivo, provide ideal material for chromosomal
analysis. With theappropriate incubation inamitotic inhibitor, syngamy is prevented and thesperm- and
egg-derived chromosomes remainasseparateclusters. Because the latterchromosomes undergocondensa-
tion sooner than those from the spermatozoon, the parental source ofchromosome sets can be identified
even without a marker chromosome. Thus these embryos can be analyzed both for the primary incidence
and the parental source ofa number ofchromosomal anomalies, including aneuploidy. By using fertiliza-
tion in vitrotoobtain theembryos, the synchronyoffertilization and nucleardevelopment issuch that80%o
ormoreofthechromosomal preparations are suitable foranalysis, compared with about 50% forembryos
fertilized in vivo.
The detection of aneuploidy in mammalian em-
bryos is dependent, to a certain extent, on the age of
the embryos, because the proportion of fetuses
which are aneuploid decreases as pregnancy ad-
vances (1). Preimplantation stages are easily recov-
ered, and the incidence of aneuploidy detected in
such embryos more closely reflects the primary inci-
dence. In anyofthese stages, however, the source of
aneuploidy, i.e., whether of maternal or paternal
origin, is not unequivocal due to the mingling ofthe
two sets of chromosomes at syngamy, prior to first
cleavage, which restores thediploid state. Ifanalysis
is carried out before syngamy, the incidence of
aneuploidy and indeed other chromosomal
anomalies can be assessed in both maternal and pa-
ternal contributions. Using the mouse, we have de-
veloped a system which permits such analysis in a
highproportion offirst-cleavage embryos examined.
The unique feature ofthe system is the use offertili-
zation in vitro to obtain the embryos for analysis.
Embryos fertilized in vivo have also proved suitable,
although the former yield a higher proportion of
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scoreablepreparations becauseofgreatersynchrony
of fertilization in vitro and subsequent nuclear de-
velopment. With the appropriate application of a
mitotic inhibitorin vitro, the egg- and sperm-derived
chromosomes do not mingle, but rather remain in
discrete clusters, thus making possible the assess-
ment of both parental contributions to the zygote,
and hence the primary incidence as well as source of
anomalies.
Although we have not examined the effects of
mutagensontheincidence ofaneuploidy, oursystem
could be used for this purpose quite easily. We
therefore describe the basic techniques and then dis-
cuss results we have obtained in experiments where
factorsotherthanmutagens, e.g., geneticones, were
being examined for their effect on gamete interac-
tions and subsequent polyploidy and aneuploidy.
Materials and Methods
Mice
Mice from a large number of mouse strains have
been used as both egg and sperm donors, including
the inbred C57BL/10, CBA, DBA/2, CBA/H-T6,
(C57BL/10 x CBA) Fl and the outbred TO. Strains
differ in the number of eggs shed in response to
exogenous hormones and in the sperm quality. For
routine work, gametes from TO and (C57BL/10 x
141CBA) Fi mice haveprovided consistently high levels
offertility which is ofparticular importance for fer-
tilization in vitro.
All female mice were induced to superovulate by
the administration of exogenous hormones. Super-
ovulation has three advantages: (1) there is greater
yield of eggs/mouse [20-40/female, depending on
strain of mouse; (2)], (2) there is a synchrony of
ovulation, and (3) the eggs obtained will be recently
ovulated. The last is an important consideration for
fertilization in vitro, since aged eggs are less fertile
and more susceptible to parthenogenetic (spontane-
ous) development (3). Adult (2-4 month old) virgin
females were injected intraperitoneally (IP) with 7.5
I.U. pregnant mare serum (PMS: Gestyl, Organon)
and approximately 48 hr later with 5.0 I.U. human
chorionic gonadotrophin (hCG: Pregnyl, Organon),
also given I.P. Depending on the strain of mouse
used, ovulation will be complete 12-14 hr afterinjec-
tion of hCG (2).
Adult (2-4 month old) males are used either for
mating in vivo or as sperm donors for fertilization in
vitro. All micearemaintained on alightcycleof14 hr
light and 10 hr dark.
Fertilization in vitro
The medium usedfor all manipulations ofgametes
is a simple salt solution based on Tyrode's solution,
plus pyruvate, lactate, and bovine serum albumin
(BSA). Forfertilization, the medium contains 32 mg
BSA (Armour)/ml and forculture, 4 mg BSA/ml (4).
Sperm suspensions are prepared by placing two
cauda epididymides into a plastic culture dish (30
mm) containing 1 ml of fertilization medium and
overlaidwithparaffin oil (4). Spermatozoaareforced
out by exerting pressure with two pairs of watch-
maker's forceps, allowed to disperse for 20 min, and
thendiluted to aconcentration ofapproximately 2 x
106 spermatozoa/ml, although this can be varied and
still permit high levels of fertilization (4, 5). The
diluted suspension is transferred to a culture dish
containing only paraffin oil.
Females are killed 13-14 hr after hCG, i.e. upon
completion of ovulation, and the oviducts are re-
moved; unfertilized eggs are then released from the
oviductsdirectlyintothediluted sperm suspensions.
The dishes are placed in an anaerobic culture jar
which isgassedwitheither5%C02 inairor5% C02,
5%02, 90o N2; alternatively, a C02 incubator, if
available, can be used.
After incubation for 6 hr at 37°C, the eggs are
removed from the sperm suspensions, washed once
in culture medium and transferred to a small droplet
of culture medium, containing vinblastine sulfate,
10-5 mM (Velbe, Lilly), under oil and cultured over-
night. The following morning chromosome prepa-
rations are made. In our experience, eggs lacking a
second polar body at the end of the 6 hr incubation
are almost always unfertilized and these are usually
discarded; thus, relatively rare digynic embryos may
be missed.
Chromosome Preparations
The methods used are essentially those of Tar-
kowski(6), withashortexposure ofthe embryos to a
hyptonic citrate solution followed by fixation with
methanol:acetic acid (7). Preparations are stained
with 1% aqueous toluidine blue and after examina-
tion, slides can be washed, dried and stored for later
re-examination if desired.
Difficulties in interpretation are encountered in-
frequently and the majority of all counts are confi-
dent. If a chromosome spread suggests excessive
scatter with accompanying loss ofchromosomes, it
is rejected. The fact that each embryo consists of a
singlecellwithdiscrete pronucleireducesthechance
ofoverlap that is frequently encountered with later,
multicellular stages. There is the added advantage
thatall the embryos, assumingnormal development,
will enter mitosis for the first-cleavage during the
period of incubation in the mitotic inhibitor.
Fertilization in vivo
Females are injected with hCG 13 hr prior to the
estimated time of sponteneous ovulation and then
paired overnight with males. If vaginal plugs, indi-
cating mating, are found the following morning, the
females are killed inthe late afternoon; the fertilized,
1-cell embryos are recovered, washed, and cultured
overnight in medium containing Velbe, then pro-
cessedasdetailedabove. We havefound thatifthese
embryos are put into the mitotic inhibitor too early,
thechromosome condensation is frequently stopped
at late prophase and the resulting preparations can-
not be analyzed for aneuploidy; for this reason, we
stipulate late afternoon as the time for embryo re-
covery.
Equipment Needed for Fertilization in vitro
And Embryo Culture
Equipment required is an incubator, anaerobic
culturejar, dissecting microscope, gas mixture (5%
C02 in air or 5% C02, 5% 02, 90% N2), water bath,
gas washing bottle, and warming tray.
Results
The overnight incubation of recently fertilized
mouse embryos in amitotic inhibitoreffectively pre-
Environmental Health Perspectives 142FIGURE 1. Diploid first-cleavage mouse embryo; sperm donor was a CBA/T6 male and the T6 marker chromosome is denoted by the
arrow: (e,) male-derived complement; (9) = female-derived complement; pb = second polar body.
vents syngamy, and the egg- and sperm-derived
chromosomes are visible as distinctgroups. Initially
we used CBA/H-T6 males in order to have a distin-
guishing marker in the chromosome set contributed
by the spermatozoon (Fig. 1), but it became evident
that sufficient differences existed between maternal
and paternal contributions to make a marker unnec-
essary. The maternally derived chromosomes ex-
hibit a greaterdegree ofcondensation and thus stain
more intensely and are generally more widely dis-
persed than are the paternally-derived ones. These
features have infactbeen noted by otherworkers (8,
9)andused in mutagen studies(10, 11). Fromasingle
preparation we can determine whether one or more
spermatozoa have fertilized the egg, and in most
embryos the female complementcan be assessed for
aneuploidy, although comparable analysis of the
male complement is sometimes made difficult be-
cause these chromosomes, condensing later as they
do, may still be in late prophase.
The most notable difference we have been able to
detect using the in vivo and in vitro systems just
described is the significantly higher incidence of
polyspermy, primarily dispermy, in first-cleavage
embryosfertilized in vitro when compared with ones
fertilized in vivo. In a typical series, 64/452 (14.2%)
embryos fertilized in vitro were polyspermic, 60
being dispermic triploids and four being trispermic
tetraploids, comparedwith only4dispermictriploids
out of 228 (1.8%) embryos fertilized in vivo (7).
Another interesting result has been the observation
that about 1% ofthe fertilizing spermatozoa in the in
August 1979 143vitro group have had diploid chromosome comple-
ments, while only one such spermatozoon has been
detected following natural mating (5, 7, 12, 13). The
increase in polyspermy in vitro is, in part, due to the
relatively high sperm concentration used when com-
pared with in vivo conditions (5). We have also ob-
tained evidencethateggs recovered after ahigh dose
of PMS (7.5 I.U.) are more susceptible to poly-
spermy than those recovered after a low dose (1.5
I.U.)ofthe hormone (7). Thispresumably reflects an
effectofsuperovulation onthe zonapellucida, which
surrounds the egg and through which spermatozoa
must pass in order to achieve fertilization, so that
more spermatozoa are able to penetrate the zona
simultaneously. There was no corresponding effect
on the incidence of aneuploidy, however.
Combined datafrom several series ofexperiments
reveal no significant difference (Fisher's exact test)
in the incidence of male-and female-derived
monosomy and trisomy within either group of em-
bryos (Table 1), and there is also good agreement
between embryos fertilized in vivo and in vitro with
respecttob+1 andn-I counts. The somewhat higher
incidence ofn-I counts inthe female complements in
vitro is probably due to the greaterdispersal ofthese
chromosomes noted inpreparations, resultinginloss
due to scattering. Certainly there is close agreement
for the n+1 counts, which are less subject to ar-
tefactual production. To calculate the embryonic in-
cidence, the total number ofaneuploid counts (male
+ female) is divided by 2. Since the female counts
usually exceed the male ones, the resulting figure is
anapproximation, albeit a close one, ofthe absolute
incidence ofembryonic aneuploidy. Typical prepa-
rations from aneuploid embryos in which all groups
of chromosomes can be counted are shown in Fig-
ures 2-4.
Inone experimental series, fivedifferent strains of
mice were used as egg donors and TO males were
used as sperm donors (13). Within the in vivo and in
vitro groups, no significant differences were found
between male- and female-derived aneuploidy, and
thesedatahave been combined to give anembryonic
incidence (Table 2). Furthermore, there were no sig-
nificant differences between the two groups of em-
bryos in the incidence of aneuploidy.
Of the two groups ofembryos, those fertilized in
vitro give a higher proportion ofpreparations which
can be scored for aneuploidy i.e., generally >80%
compared with about 50%o for embryos fertilized in
vivo, and both maternal and paternal contributions
canbe analyzed in more ofthe formerthanthe latter,
a considerable proportion of male complements
being at late prophase in the in vivo group (Table 2).
This advantage is due primarily to the much greater
synchrony offertilization achieved in vitro, where a
fixed pool of eggs is used and an adequate concen-
tration of spermatozoa is present throughout. The
datain Table 3 illustrate the synchrony conferred by
the in vitro system. Whether the spermatozoa are
capableoffertilizingimmediately(preincubated2hr)
orbecome soduringthe incubation with eggs (prein-
cubated 30 min), within 1 hr 15 min the eggs are
fertilized, and the majority ofembryos in each group
are all at the same approximate stage of egg activa-
tion (completion of meiosis II) and sperm head de-
condensation. When natural mating is used, the eggs
are shed over a period of 2 hr or more (2), and the
concentration ofspermatozoa may be a limiting fac-
tor; thus, in an individual female, fertilization may
occur, over a period ofseveral hours. Furthermore,
there is no obvious synchrony of mating and, con-
sequently, different females will have embryos in
differentpost-fertilization stages atrecovery. Prepa-
rations unsuitable for analysis ofaneuploidy usually
eitherhavethe male elements still atlate prophase or
have a single group ofchromosomes (40+), indicat-
ingthatthe embryos were atastage too advancedfor
the mitotic inhibitor to prevent syngamy. Both fac-
tors are particularly associated with embryos fer-
tilized in vivo because of the asynchronous mating
and fertilization discussed above.
In only one experimental series have we observed
a significant difference in aneuploidy attributable to
one or other parental source. In comparing the inci-
dence of aneuploidy in eggs obtained from young
virgin and old parous females, a significantly higher
incidence oftrisomy was noted in the eggs from old
Table 1. Combined data on the incidence of aneuploidy in first-cleavage mouse embryos fertilized
in vivo and in vitro: monosomy, trisomy, and total aneuploidy.a
Male-derived Female-derived Embryonic
complement (%) complement incidence
n+1 In vivo 2/ 744 (0.27) 4/ 935 (0.43) 6/ 840 (0.71)
In vitro 8/1880 (0.43) 9/1925 (0.47) 17/1903 (0.89)
n-i In vivo 2/ 744 (0.27) 4/ 935 (0.43) 6/ 840 (0.71)
In vitro 4/1880 (0.21) 19/1925 (0.99) 23/1903 (1.21)
"Total embryonic incidence (2n± 1) in vivo, 12/ 840 (1.43); in vitro, 40/1903 (2.10).
Environmental Health Perspectives 144FIGURE 2. Trisomic first-cleavage mouse embryo. Sperm donor was a CBA/H-T6 male and the male-derived complement has 21
chromosomes. From Maudlin and Fraser (13) with permission.
Table 2. Incidence of aneuploidy in first-cleavage mouse embryos derived from eggs of five strains of
females and fertilized in vitro and in vivo with TO spermatozoa.
No. of embryos (%)
Egg donor Fertilization Scored Monosomic Trisomic Total aneuploid
DBA/2 In vitro 174 3 (1.7) 1 (0.6) 4 (2.3)
In vivo 20 0 (0) 0 (0) 0 (0)
CBA In vitro 90 1 (1.1) 0 (0) 1 (1.1)
In vivo 29 0 (0) 0 (0) 0 (0)
C578L/10 In vitro 110 2 (1.8) 1 (0.9) 3 (2.7)
In vivo 47 0 (0) 0 (0) 0 (0)
TO In vitro 160 5 (3.1) 2 (1.3) 7 (4.3)
In vivo 215 1 (0.5) 2 (0.9) 3 (1.4)
(C5BL/10 x In vitro 166 2 (1.2) 2 (1.2) 4 (2.4)
CBA) Fi In vivo 205 2 (1.0) 1 (0.5) 3 (1.5)
aFrom Maudlin and Fraser (13).
August 1979 145FIGURE 3. Trisomic first-cleavage mouse embryo; sperm donor was a TO male and thus there is no marker chromosome. The
female-derived complement has 21 chromosomes.
females, and this was due to an increase in the inci-
dence of n +1 egg-derived, rather than sperm-
derived, complements [(Table 4) (14)].
Discussion
The methods detailed above provide rapid, accu-
rate and efficient analysis of chromosomes in the
first-cleavage mouse embryo. Largenumbersofeggs
are obtained when ovulation is stimulated with ex-
ogenous hormones (mean of 20-40/mouse) (2), and
we have routinely processed up to 200 eggs/per day
with one person making the preparations. Given the
high proportion of preparations which are suitable
foranalysis, it isclearthat agreatdealofinformation
can be obtained in a relatively short period oftime.
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Because ofthe differential condensation ofmaternal
and paternal chromosome complements, the source
of aneuploidy can be accurately assigned; indeed,
Table 3. Synchrony offertilzation in an in vitro system.a
Sperm pre- Telophase- Full sperm
incubation second head decon-
time, hr Fertilized Anaphase polar body densation
0.5 79/91 67/79 12/79 3%
(87%) (85%) (15%)
2 68/75 16/68 52/68 61%
(91%) (24%) (76%o)
aSperm suspensions were preincubated for the time noted, di-
luted and eggs were added. After 1 hr 15 min, eggs were fixed in
buffered formalin, stained and assessed for fertilization.
Environmental Health PerspectivesFIGURE 4. Tetrasomic dispermic triploid first-cleavage mouse embryo. The two sets ofmale-derived chromosomes have 20 each, the
female-derived complement, 22. From Maudlin and Fraser (13), with permission.
either or both parent could be treated with potential
mutagens and the incidence ofanomalies from each
source determined independently.
In the methods described here, two procedures
might be objected to for possible effects on aneu-
ploidy, namely superovulation and fertilization in
vitro. While most of our studies have used both in
vivo and in vitro fertilization and have detected no
differences in aneuploidy, all eggs were obtained by
superovulation and so any effect on nondisjunction
should be present in both groups. A recent study by
Takagiand Sasaki (15)has specificallyexaminedthis
possibility and theirdata reveal no significant differ-
ences between eggs obtained by superovulation and
spontaneous ovulation in the incidence of aneu-
ploidy.
With respect to fertilization in vitro, our results
indicate that the system itself does not generate
aneuploidy, there being no significant differences
between embryos fertilized in vivo and in vitro.
There is no evidence either that the completion of
meiosis II by the oocyte in an in vitro environment
hasanyeffectonnondisjunction orthatspermatozoa
with abnormal chromosome numbers are selected
fororagainstin vitro,atleastwithrespectton+1 and
n - 1 complements. The one notable exception lies
with spermatozoapossessing a diploid complement.
Here there is a definite advantage in vitro for such
gametes, with about 1% of all fertilization in vitro
being accomplished by diploid spermatozoa while
only 1 has been found in all ofthe in vivo fertilized
embryos (> 2000) examined. This is not too surpris-
August 1979 147Table 4. Incidence of aneuploidy in first-cleavage mouse embryos derived from the eggs of
old parous and young virgin TO females and fertilized in vitro with TO spermatozoa.a
Monsomic Trisomic Total aneuploidsb
Old Young Old Young Old Young
Female-derived complement 9 (2.4%) 7 (1.6%) 12 (3.2%)c 4 (0.9%o) 21/375 (5.6%)c 11/434 (2.5%)
Male-derived complement 0 (0%7) 2 (0.5%) 4 (1.4%) 1 (0.2%) 4/293 (1.4%) 3/419 (0.7%)
Embryonic incidence 9 (2.7%) 9 (2.1%) 16 (4.8%)d 5 (1.2%) 25/334 (7.5%)c 14/427 (3.3%)
aData of Maudlin and Fraser (14).
bNo. ofaneuploid embryos/total embryos scored.
Cp = 0.05 - 0.01.
dp = 0.01 - 0.001.
ing, since the female mouse reproductive tract,
specifically the uterotubaljunction, apparently acts
as a barrier to the majority of morphologically ab-
normal spermatozoa (16). The diploid gametes,
having larger heads, are thus normally screened out
in vivo. Of course, a comparison of embryos fer-
tilizedin vitro and matched controls fertilizedin vivo
can quickly ascertain whether any selection is act-
ing.
Further evidence that in vitro conditions do not
alter the incidence ofaneuploidy is provided by our
observation, usingfreshlyovulatedeggs(i.e., notold
eggs) from old females, that there is a significantly
increased incidence ofn+1 maternally derived com-
plements when these eggs are fertilized in vitro.
These results are consistent with a recent study by
Martin, Dill, and Miller (17), in which a significantly
higher incidence ofhyperploidy (n+ 1) was found in
metaphase II oocytes from old CBA females com-
pared with those from young mice. Assuming fertili-
zation by haploid spermatozoa and normal comple-
tionofmeiosis II, suchoocytes wouldgive rise to the
trisomic embryos detected in our study.
While it is obvious that our methods are most
easily applied to studies utilizing the mouse, these
basic techniques have recently been used to analyze
human spermchromosomes afterfertilization, notof
human eggs, but ofhamster eggs (18). Briefly, since
mature human metaphase II oocytes are difficult to
obtain, hamster eggs have been used to test the fer-
tilizing ability ofhuman spermatozoa. To overcome
the species specificity barrier, the zonae pellucidae
are removed from hamster eggs and the human
sperm suspensions then added. Having successfully
fused with an egg, at least some spermatozoa can
respond to the signals within the egg and undergo
pronuclear formation; with the addition ofa mitotic
inhibitor, the chromosomes ofthe spermatozoa can
thenbeanalyzed. Thusfaronly60spermatozoahave
been analyzed in this manner and the incidence of
aneuploidy was 5%, considerably higher than our
figures for mouse spermatozoa.
The in vitro technique itself requires relatively
simpleequipment and with acertain amount ofprac-
tice can yield consistent results. Indeed, the tech-
niques used inourlaboratory have been successfully
transplanted to another laboratory and are continu-
ing to give high levels offertilization. The combina-
tion of in vitro fertilization and chromosomal
analysis at first cleavage provides not only an ex-
tremely efficient method for analyzing the primary
incidence ofaneuploidy in mammalian embryos, but
also a versatile one as evidenced by the human-
hamster experiments discussed above. The fact that
both maternal and paternal contributions can be as-
sessed independently means that studies utilizing
potential mutagens could obtain maximal informa-
tion on the incidence of a variety of chromosomal
anomalies.
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